|
|
|
|
| LEADER |
02505nam a22004095i 4500 |
| 001 |
978-1-59745-134-5 |
| 003 |
DE-He213 |
| 005 |
20150519185353.0 |
| 007 |
cr nn 008mamaa |
| 008 |
111201s2012 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781597451345
|9 978-1-59745-134-5
|
| 024 |
7 |
|
|a 10.1007/978-1-59745-134-5
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a QR1-502
|
| 072 |
|
7 |
|a PSG
|2 bicssc
|
| 072 |
|
7 |
|a SCI045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 579
|2 23
|
| 245 |
1 |
0 |
|a Interactions of Yeasts, Moulds, and Antifungal Agents
|h [electronic resource] :
|b How to Detect Resistance /
|c edited by Gerri S. Hall.
|
| 264 |
|
1 |
|a Totowa, NJ :
|b Humana Press,
|c 2012.
|
| 300 |
|
|
|a XIV, 170 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 505 |
0 |
|
|a Antifungal Agents -- Antifungal Susceptibility Testing: Clinical Laboratory and Standards Institute (CLSI) Methods -- Antifungal Susceptibility Testing Methods – Non CLSI Methods for Yeast and Moulds -- Susceptibility Testing of Dermatophytes -- Usual Susceptibility Patterns of Common Yeasts -- Usual Susceptibility Patterns of Common of Moulds and Systemic Fungi -- Usual Susceptibility Patterns for Systemic Dimorphic Fungi -- Utility of Antifungal Susceptibility Testing and Clinical Correlations.
|
| 520 |
|
|
|a The incidence of fungal infections increases with the increase in antibiotic usage and increasing immunosuppressed populations. There is no longer only one antifungal agent and the response of fungi to various agents is not always predictable. The need for standardized antifungal susceptibility testing, and standardized interpretation of results in conjunction with studies that describe clinical outcomes based on those tools is ever important. Interactions of Yeasts, Moulds, and Antifungal Agents: How to Detect Resistance covers the available antifungal agents, how to perform in vitro testing and how those results should be interpreted for the most common fungal pathogens.
|
| 650 |
|
0 |
|a Life sciences.
|
| 650 |
|
0 |
|a Microbiology.
|
| 650 |
1 |
4 |
|a Life Sciences.
|
| 650 |
2 |
4 |
|a Microbiology.
|
| 700 |
1 |
|
|a Hall, Gerri S.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9781588298478
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-59745-134-5
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
